Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene.

Gastro-Esophageal Reflux Disease (GERD)

Key Findings

The oral administration of beta-caryophyllene to rats significantly inhibited gastric mucosal injuries induced by necrotizing agents such as absolute ethanol and 0.6 N HCl. Thus, beta-caryophyllene elicited anti-inflammatory effects without any indication of gastric mucosal damage typical of non-steroidal anti-inflammatory agents.

Information and Links


Link: Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene.

Year: 1996


Ratings

(How Ratings Work)

Gastro-Esophageal Reflux Disease (GERD) — 2


Possible to probable range of efficacy of cannabis for treatment of Gastro-Esophageal Reflux Disease (GERD) according to the results found in this study.

Drugs Used

Beta-caryophyllene